lorazepam has been researched along with ipsapirone in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peroutka, SJ | 1 |
| Cutler, NR; Hesselink, JM; Roeschen, JK; Sramek, JJ; Wardle, TS | 1 |
| Cutler, NR; Keppel Hesselink, JM; Krol, A; Rickels, K; Roeschen, J; Schweizer, E; Sramek, JJ | 1 |
| Cutler, N; Keppel Hesselink, JM; Mandos, LA; Rickels, K; Roeschen, J; Schweizer, E | 1 |
| Bologa, M; Bremner, KE; Busto, UE; Naranjo, CA; Peachey, JE | 1 |
4 trial(s) available for lorazepam and ipsapirone
| Article | Year |
|---|---|
The safety and efficacy of ipsapirone vs. lorazepam in outpatients with generalized anxiety disorder (GAD): single site findings from a multicenter trial.
Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Double-Blind Method; Female; Humans; Lorazepam; Male; Psychiatric Status Rating Scales; Pyrimidines | 1993 |
A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Double-Blind Method; Female; Humans; Lorazepam; Male; Prospective Studies; Psychiatric Status Rating Scales; Pyrimidines; Substance Withdrawal Syndrome | 1993 |
Placebo-controlled comparison of the clinical effects of rapid discontinuation of ipsapirone and lorazepam after 8 weeks of treatment for generalized anxiety disorder.
Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Female; Humans; Lorazepam; Male; Placebo Effect; Psychiatric Status Rating Scales; Pyrimidines; Substance Withdrawal Syndrome; Treatment Outcome | 1995 |
Safety of ipsapirone treatment compared with lorazepam: discontinuation effects.
Topics: Adult; Anti-Anxiety Agents; Double-Blind Method; Humans; Lorazepam; Male; Prospective Studies; Pyrimidines; Substance Withdrawal Syndrome | 1998 |
1 other study(ies) available for lorazepam and ipsapirone
| Article | Year |
|---|---|
Selective interaction of novel anxiolytics with 5-hydroxytryptamine1A receptors.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anti-Anxiety Agents; Binding, Competitive; Brain; Buspirone; Cattle; Depression, Chemical; Diazepam; Flunitrazepam; In Vitro Techniques; Lorazepam; Pyrimidines; Receptors, Serotonin; Tetrahydronaphthalenes | 1985 |